Skip to main content

Table 5 Comparison between HEP and LF in patients with known or suspected cardiac sarcoidosis

From: Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

  HEP LF p value
  N Average ± SD N Average ± SD
Age (years) 96 57.19 ± 13.88 69 56.94 ± 13.16 0.91
Gender 96 M/F = 37:59 69 M/F = 17:52 0.06
FBG 96 99.68 ± 14.12 69 92.80 ± 13.35 0.002**
FFA 96 0.81 ± 0.39 69 1.02 ± 0.41 0.001**
BMI 96 22.37 ± 3.39 69 21.83 ± 3.08 0.28
Phy U 96 2.46 ± 1.33 69 1.48 ± 0.99 <0.0001***
Steroid use 96 19 69 14 0.98
  1. HEP, heparin loading plus 12-h fasting; LF, 16-h or more fasting; FBG, fasting blood glucose (mg/dL); FFA, plasma free fatty acids (mEq/L); BMI, body mass index; Phy U, physiological uptake grades 1 to 4; ** p < 0.01; *** p < 0.001.